Navigation Links
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Date:3/24/2009

mitted to continuing to invest in this promising technology and to bring it to market as soon as possible."

The ABSORB trial reinforces Abbott's commitment to research and develop innovative devices in vascular care. Abbott's robust vascular research program includes clinical trials in peripheral artery disease, carotid artery disease, and coronary artery disease. Key products in the vascular pipeline include: the Omnilink Elite(TM) Peripheral Stent System; the EMBOSHIELD NAV6(TM) Embolic Protection System for carotid stenting; and the XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System, which builds upon the proven performance of Abbott's market-leading XIENCE V(R) Everolimus Eluting Coronary Stent System.

Onmilink Elite, EMBOSHIELD NAV6 and XIENCE PRIME are investigational devices and are not available for sale.

About the ABSORB Clinical Trial

The ABSORB trial is a prospective, non-randomized (open label), two-phase study designed to enroll approximately 110 patients in Australia, Belgium, Denmark, France, the Netherlands, New Zealand, Poland and Switzerland. Key endpoints of the study include assessments of safety - MACE and stent thrombosis rates - at 30 days; six, nine, 12 and 18 months; and two years, with additional annual clinical follow-up for up to five years, as well as an assessment of the acute performance of the bioabsorbable drug eluting stent, including successful deployment of the system. Other key endpoints of the study include imaging assessments by angiography, intravascular ultrasound (IVUS), optical coherence tomography (OCT), and other state-of-the-art invasive and non-invasive imaging modalities at six months, one year and two years.

Abbott's bioabsorbable drug eluting device delivers everolimus, a drug that inhibits tissue proliferation. The device props open and supports a narrowed blood vessel until the vessel heals, restoring blood flow, and is abs
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
2. Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor
3. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
4. Abbotts XIENCE V(TM) Drug Eluting Stent Outperforms TAXUS(R) in Key Efficacy and Safety Endpoints Out to Two Years
5. Continuous Treatment With Abbotts HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
6. Abbotts Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
7. Abbotts Phase III Sub-Group Analysis Shows Investigational TriLipix(TM) in Combination with CRESTOR(R) Improves Key Lipids in Patients with Mixed Dyslipidemia and Type 2 Diabetes
8. Phase III Study of Abbotts Investigational TriLipix(TM) in Combination With AstraZenecas CRESTOR(R) Meets Primary Endpoints on Key Lipids
9. Abbott Presents Long-Term Data From Extension Study Showing Adult Crohns Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
10. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... quarter and fiscal 2014 ended July 31, 2014 on Monday, ... call to discuss the results at 11:00 AM ET. Participating ... Chairman; Andrew A. Krakauer , President and CEO; ... Craig A. Sheldon , Senior Vice President, CFO and Treasurer; ...
(Date:9/22/2014)... 2014  Inovio Pharmaceuticals, Inc. (NASDAQ: ... phase I clinical trial in patients with aerodigestive ... and immunogenicity of INO-3106. This immunotherapy targets human ... cancers. Aerodigestive cancers affect the lips, ... of the esophagus and windpipe. The unmet need ...
(Date:9/22/2014)... , Sept. 22, 2014  Seres Health, a ... to the human microbiome, today announced that it has ... 2014,s Fierce 15 biotechnology companies, designating it as one ... industry.  "Amid a great deal of ... its focus and commitment to practical therapeutic development," says ...
Breaking Medicine Technology:Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 2Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 3Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers 4Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... Morgan honored with The TIME Award for ... National Council for Prescription Drug Programs (NCPDP), a not-for-profit ... services industry, awarded Kay Morgan, Senior Vice President of Drug ... / Gold Standard , with its highest honor, The TIME ...
... 17, 2012 SurgLine International, Inc. (SGLN.PK) ... stated that the Company has acquired Eden Surgical Technologies, ... a distributor of trauma products with extensive products focused ... pleased to announce today that we have acquired Eden ...
Cached Medicine Technology:Elsevier / Gold Standard's Kay Morgan Awarded NCPCP Highest Honor 2Elsevier / Gold Standard's Kay Morgan Awarded NCPCP Highest Honor 3SurgLine International, Inc. to Expand its Trauma Product Line With Completion of Acquisition 2
(Date:9/22/2014)... Oregon (PRWEB) September 22, 2014 During ... key leaders from the Oregon long-term care and senior ... the extra mile for the well-being of others. ... for Avamere Health Services, will be awarded the OHCA ... by OHCA staff to members who assist OHCA in ...
(Date:9/22/2014)... Airbus Helicopters Inc. (AHI) honored leaders of ... to improve safety and quality of service. The annual ... the Year award, both sponsored by AHI, were presented ... Community Awards. , PHI Air Medical President ... Safety Award, given annually to an individual who has ...
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 On ... Radio Network launched their first evening show, “KC After Dark.” ... Marcus Edwards, “KC After Dark” will air every Tuesday at ... a free iPad for the 50th caller, and because of ... well past the call in mark with 500 callers. ...
(Date:9/22/2014)... Fremont, CA (PRWEB) September 22, 2014 ... state-of-the-art treatment for patients who require orthodontic work. Six-Month ... beautiful smile they deserve in a fast and effective ... work to be extremely daunting. Having to wear metal ... avoid certain foods and spend time keeping the braces ...
(Date:9/22/2014)... 2014 On Saturday, September 27, UHY LLP ... local nonprofit that is doing an amazing job helping kids ... employees, their families and friends will be spending the day ... cement games and graphics, as well as clean the playground ... scheduled to occur in May but due to weather conditions ...
Breaking Medicine News(10 mins):Health News:Avamere Family of Companies Regional Director Nominated for the Oregon Health Care Association 2014 Special Service Award 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 3Health News:The Women’s Radio Network, WRNW1’s First Evening Show a Huge Success 2Health News:Starbrite Dental Introduces Six-Month Smiles 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3
... , DOYLESTOWN, Pa., Dec. 7 ... the speakers at the Galen Institute,s "The Value of Innovation ... Wednesday, December 9th in Washington DC at the Columbus Club ... public policy research organization focusing on health and tax policy. ...
... MIAMI, Dec. 7 A couple years ago, lead paint ... gifts made in the USA. This fall, news of Baby ... Renowned parenting expert Dr. Jeffrey Fine, Ph.D., says that such ... and shortening attention spans. Moreover, there is an increased sense ...
... ... first, social networking community developed by, and dedicated to, persons with illnesses and disabilities ... like minds, circumstances and situations while maintaining as much, or as little privacy as ... Milwaukee, ...
... 7 The National Health Service (NHS), which manages 500 ... the value of an engaged staff: healthier and happier patients. ... of care, many NHS hospitals are teaming up with international ... leaders. , "Staff engagement is essential to meeting the financial ...
... , , ... Factory, ( www.cubiclecurtainfactory.com ), has retained TransMedia Group to ... decades, the Simply 66 Snap System, which is already ... ( www.transmediagroup.com ) was selected as Agency of Record to ...
... , , BOCA RATON, ... the market leader in all-natural herbal and homeopathic remedies for ... as their PR firm of record. The company,s two brands, ... provide complete lines of safe, scientifically-tested, guaranteed products that promote ...
Cached Medicine News:Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2Health News:Top 10 Toys That Will Scar Your Child for Life 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:The NHS to Improve Patient Care by Better Engaging Staff 2Health News:Cubicle Curtain Factory Retains TransMedia Group to Promote First Privacy Curtain to Reduce Hospital Maintenance Cost 2Health News:Native Remedies and PetAlive.com Hires TransMedia Group to Herald Herbal for People and Pets 2
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Inquire...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: